Selected region : north
Date: : 26th Jun 2019

For All Current Studies ongoing in the North click HERE.

SHARE Studies


Researchers at the University of Edinburgh aim to understand the genetic susceptibility to coronavirus infection. They will also examine the genetic influences on the severity and outcomes of coronavirus, particularly for less severe cases. The focus will not just be individuals who are admitted to hospital and critical care.

They are looking for both participants who are suffered from COVID-19 and those who have not. People who have not contracted the disease or had symptoms are just as important to the study as people who have.

For more information about this study please click here.


The University of Edinburgh are running a study called ELVIS COVID-19 to find out if nasal washout and gargling with salt water helps individuals with COVID-19 get better faster by helping to ease the symptoms of the virus.

If you have developed symptoms of COVID-19 including a continuous cough or high temperature or loss of sense of smell or taste within the past 48 hours, the study team would appreciate your help with this study.

For more information about this study please click here.

 Other studies ongoing in the North of Scotland

For more information  All Current Studies ongoing in the North click HERE.

Lowering Events in Non-proliferative retinopathy in Scotland

The aim of this study is to evaluate if fenofibrate therapy will slow the progression of diabetic retinopathy.

Comparing treatments for diabetic foot ulcers

The aim of this study is to find out the best combination of treatments to use to help DFUs heal more quickly by measuring the size of the ulcer and comparing the healing to the different treatment options.

An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread

The purpose of this study is to investigate treatment with nivolumab in combination with trametinib with or without ipilimumab in participants with previously treated cancer of the colon or rectum that has spread.

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

The primary objective of Enroll-HD is to develop a comprehensive repository of prospective and systematically collected clinical research data (demography, clinical features, family history, genetic characteristics) and biological specimens (blood) from individuals with manifest HD, unaffected individuals known to carry the HD mutation or at risk of carrying the HD mutation, and control research participants (e.g., spouses, siblings or offspring of HD mutation carriers known not to carry the HD mutation).

Is Lipid Mapping an Effective Early Detection Tool for Breast Cancer in High-risk Populations?

This study aims to investigate if lipid composition mapping using magnetic resonance imaging could improve early and accurate cancer detection in genetic mutation carriers at high risk of breast cancer.

A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis

This study will evaluate the efficacy and safety of ocrelizumab ( Ocrevus®) compared with placebo in participants with primary progressive multiple sclerosis (PPMS), including participants later in their disease course. This study focuses on upper limit disability progression.